Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.4 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |